Tencent invests in innovative drug research and development company Danxu Bio, which is dedicated to antibody drug research and development

Danxu Bio is a biopharmaceutical developer dedicated to the research and development of antibody drugs using its single-cell sequencing technology platform, and continues to promote innovative drug research for various indications including infectious diseases and autoimmune diseases , the main products are the new coronavirus neutralizing antibodies DXP-593 and DXP-604. The company recently received strategic investment from Tencent.

This article is reproduced from: https://www.itjuzi.com/investevent/13440180
This site is for inclusion only, and the copyright belongs to the original author.

Leave a Comment

Your email address will not be published.